UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 853

Sortiert nach

Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series

Human immunology, 2024-05, Vol.85 (3), p.110787-110787, Article 110787

2024

Volltextzugriff (PDF)

Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: An observational study

Medicine (Baltimore), 2023-12, Vol.102 (49), p.e36504-e36504

2023

Volltextzugriff (PDF)

Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study

Transplantation and cellular therapy, 2024-09, Vol.30 (9), p.916.e1-916.e12

2024

Volltextzugriff (PDF)

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Seminars in arthritis and rheumatism, 2020-08, Vol.50 (4), p.776-790

2020

Volltextzugriff (PDF)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation

Clinical pharmacokinetics, 2018-02, Vol.57 (2), p.191-207

2018

Volltextzugriff (PDF)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study

Annals of hepatology, 2020-09, Vol.19 (5), p.541-545

2020

Volltextzugriff (PDF)

A heart transplant center experience with basiliximab induction strategies: A double edged sword?

Clinical transplantation, 2024-04, Vol.38 (4), p.e15307-e15307

2024

Volltextzugriff (PDF)

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Journal of hematology and oncology, 2022-03, Vol.15 (1), p.22-13, Article 22

2022

Volltextzugriff (PDF)

Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal

Clinical transplantation, 2024-02, Vol.38 (2), p.n/a

2024

Volltextzugriff (PDF)

Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies

Transplant immunology, 2023-12, Vol.81, p.101958-101958, Article 101958

2023

Volltextzugriff (PDF)

Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study

Pediatric transplantation, 2024-05, Vol.28 (3), p.e14713-n/a

2024

Volltextzugriff (PDF)

Impact of induction therapy on cytomegalovirus infection and post‐transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis

Clinical transplantation, 2023-01, Vol.37 (1), p.e14836-n/a

2023

Volltextzugriff (PDF)

Basiliximab therapy for immune‐mediated bowel disease in a pediatric heart transplant patient

Pediatric transplantation, 2023-03, Vol.27 (2), p.e14443-n/a

2023

Volltextzugriff (PDF)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia

Frontiers in immunology, 2022-11, Vol.13, p.1017850-1017850

2022

Volltextzugriff (PDF)

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease

Leukemia, 2020-05, Vol.34 (5), p.1229-1240

2020

Volltextzugriff (PDF)

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort

PloS one, 2020-10, Vol.15 (10), p.e0240929-e0240929

2020

Volltextzugriff (PDF)

mRNA therapeutics in cancer immunotherapy

Molecular cancer, 2021-04, Vol.20 (1), p.69-69, Article 69

2021

Volltextzugriff (PDF)

Is There a Place for Induction Therapy With Polyclonal Antibodies to Improve Renal Function After Liver Transplantation?

Transplantation, 2022-05, Vol.106 (5), p.913

2022

Volltextzugriff (PDF)

The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients

American journal of transplantation, 2016-08, Vol.16 (8), p.2334-2341

2016

Volltextzugriff (PDF)

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease

Frontiers in immunology, 2024-07, Vol.15, p.1408211

2024

Volltextzugriff (PDF)

Successful kidney transplantation after COVID‐19

Transplant international, 2020-10, Vol.33 (10), p.1333-1334

2020

Volltextzugriff (PDF)

Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk

Transplantation, 2020-03, Vol.104 (3), p.613

2020

Volltextzugriff (PDF)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience

Frontiers in immunology, 2022-06, Vol.13, p.864545-864545

2022

Volltextzugriff (PDF)

Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients

Transplant immunology, 2023-10, Vol.80, p.101899-101899, Article 101899

2023

Volltextzugriff (PDF)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Journal of hematology and oncology, 2019-09, Vol.12 (1), p.88-9, Article 88

2019

Volltextzugriff (PDF)

1 – 25 von 853

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(813)
Mit Volltextzugriff
(779)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Basiliximab
(790)
Science & Technology
(691)
Life Sciences & Biomedicine
(676)
Humans
(508)
Transplantation
(479)
Surgery
(304)
Kidney Transplantation
(301)
Male
(300)
Female
(297)
Immunosuppressive Agents - Therapeutic Use
(297)
Antibodies, Monoclonal - Therapeutic Use
(258)
Adult
(237)
Middle Aged
(221)
Biological And Medical Sciences
(195)
Immunology
(194)
Medical Sciences
(191)
Graft Rejection - Prevention & Control
(170)
Recombinant Fusion Proteins
(140)
Treatment Outcome
(137)
Kidneys
(135)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series

Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: An observational study

Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study

A heart transplant center experience with basiliximab induction strategies: A double edged sword?

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal

Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies

Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study

Impact of induction therapy on cytomegalovirus infection and post‐transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis

Basiliximab therapy for immune‐mediated bowel disease in a pediatric heart transplant patient

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort

mRNA therapeutics in cancer immunotherapy

Is There a Place for Induction Therapy With Polyclonal Antibodies to Improve Renal Function After Liver Transplantation?

The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease

Successful kidney transplantation after COVID‐19

Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience

Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Suchergebnisse filtern